specialty clinics

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Hahn & Co., South Korea’s largest private equity firm, has finalized the acquisition of SK Specialty Co., the world’s leading produc...

Lotte Chemical Corp.'s joint venture with Japan’s Tokuyama Corp. will ramp up specialty chemicals production to accelerate its shift from...

South Korea’s private equity firm Hahn & Co. is set to acquire a controlling stake in the world’s top specialty gas producer SK Spec...

Hyosung TNC Corp., a South Korean textile and yarn maker, said on Thursday it will acquire the specialty gas division of Hyosung Chemical Corp. for ...

Daan Cancer Laboratory under Severance Hospital said on Thursday it signed a memorandum of understanding (MOU) with the Latvian government to streng...

Hyosung TNC Corp., the world’s top spandex maker, is considering taking over the specialty gas business of its chemical affiliate, news of whi...

Hyosung Chemical Corp. has failed to reach an agreement with a consortium of IMM Private Equity and STIC Investments Inc. to sell its specialty gas ...

Mediaiplus Inc., South Korea’s only provider of data analytics and contract research organization (CRO) matching services for clinical trials,...

SK Group, the second-largest conglomerate in South Korea, is considering selling global leading specialty gas producer SK Specialty Co. for around 4...

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...

South Korea’s Hyosung Group is poised to sell a 100% stake in its specialty and industrial gas unit to a consortium led by IMM Private Equity ...

Lotte Chemical Corp., South Korea’s second-largest petrochemicals company seeking to ramp up value-added advanced materials production, has de...

Affirma Capital, a Singapore-based buyout private equity firm, is seeking to sell its entire stake in both South Korean steel tube maker SeAH FS and...

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...

NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic e...

CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its i...

South Korea’s Lotte Chemical Corp. announced on Monday its commencement of commercial production at the plant of Hydroxy Ethyl Cellulose (prod...

South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...

South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...

South Korean clinical-stage biotech D&D Pharmatech Inc. has won approval from the Korea Exchange’s preliminary review for listing on the j...

Samyang Specialty Solutions LLC, a leading chemical and food products maker in South Korea, has entered into an agreement to wholly acquire Texas-ba...

LG Electronics Inc. unveiled a new medical monitor on Wednesday. This monitor boasts high brightness suitable for both clinical and diagnostic purpo...

South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

In the semiconductor industry, it’s been quite a while since memory chips became a commodity, meaning so low an entry barrier that any chipmak...